Dr. Fernando J. Kim spoke at the 24th annual Perspectives in Urology Point • Counterpoint meeting on Saturday, November 14, 2015 on Point/Counterpoint: “Selection of Active Surveillance Patients: MRIs Add More Value Than Genomic/Molecular Tests Add More Value.”

 

 

Keywords: prostate cancer, MRI, genomic molecular tests

How to cite: Kim, Fernando J. “Point/Counterpoint: Selection of Active Surveillance Patients: MRIs Add More Value Than Genomic/Molecular Tests Add More Value.” Grand Rounds in Urology. November 14, 2015. Accessed Apr 2024. https://grandroundsinurology.com/active-surveillance-genomic-molecular-tests.